SS-31 is a mitochondria-targeting peptide. It has exciting uses in biomedical research. This peptide enters the mitochondrial inner membrane and binds to cardiolipin. Cardiolipin is a unique phospholipid found only in mitochondria.
By stabilizing cardiolipin, SS-31 protects it from oxidation. This helps maintain mitochondrial integrity. SS-31 also supports mitochondrial electron transport and reduces cellular damage. It improves mitochondrial ATP synthesis and boosts ATP production. It also helps reduce harmful effects from mitochondrial reactive oxygen species (ROS), lipid peroxidation, and inflammation.
One of the key benefits of the SS-31 peptide vial is its ability to improve mitochondrial function. This is especially helpful in cells affected by aging or disease. In clinical trials, researchers have looked at how SS-31 can reduce damage from oxidative stress. SS-31 improves muscle fibers and supports cardiovascular health.
The SS-31 peptide vial also plays a role in improving muscle mass and preventing muscle loss. It has shown promise in treating mitochondrial diseases, such as age-related mitochondrial dysfunction, neurodegeneration, heart failure, and even certain forms of cancer. fra Researchers have also studied how mitochondrial protein interaction and mitochondrial proteins are affected by SS-31. This could lead to new therapeutic options.
SS-31 works in the lipid bilayers of mitochondria. It stabilizes cardiolipin and helps maintain cytochrome c stability. It prevents cell death and oxidative cell death, which is important when mitochondrial health is compromised. The peptide’s effects on mitochondrial bioenergetics and mitochondrial structure are crucial. SS-31 plays a pivotal role in preventing apoptosis and improving cell survival.
Its stabilization of mitochondrial membranes also reduces endoplasmic reticulum stress and protects against calcium overload. These effects help improve overall cellular health and energy production.
The SS-31 peptide vial also interacts with cysteine residues at key mitochondrial sites. This adds to its effectiveness. fra Researchers are studying how SS-31 may improve longevity and reduce frailty by protecting against mitochondrial dysfunction.
As more studies are done, it is becoming clear that SS-31 could reduce endoplasmic reticulum stress and disruption in key pathways. This leads to better health in areas like neuroprotection, cardiovascular research, and the prevention of chronic diseases.
Studies using nuclear magnetic resonance (NMR) show that SS-31’s interaction with mitochondrial proteins is key to maintaining mitochondrial function. This has broad effects on improving mitochondrial health, preventing dysfunction, and increasing overall cellular vitality.
Explore SS-31 peptide in more detail, on our dedicated page.
